WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

Chinese Drugmakers Face Mounting Risks From Washington Despite Tariff Relief: ... Chinese pharma firms may have escaped the immediate impact of U.S. President Donald Trump's newly announced 100% tariff on patented drugs, but longer-term threats from Wa...
(9/30/2025)

Challenges and Opportunities in Oncology Drug ... (9/23/2025)

China's Edge over U.S. Biotech Was Never Scien... (9/23/2025)

China's Role in Global Drug Approvals Expands ... (9/22/2025)

PRC Consolidates Pharmaceutical Supply Chain D... (9/19/2025)

China Biopharma at Crossroads: A... (9/19/2025)

Gottlieb Cautions Blanket China Drug Licensing... (9/19/2025)

Obesity in China (The Lancet) (9/19/2025)

China's Biotechs Navigate the Demands of Inter... (9/19/2025)

On the Cusp of a Cure: Is Asia Pacific Ready f... (9/18/2025)

Strengthening Oversight of Imported Drugs: Key... (9/18/2025)

Merger Control in China's Healthcare Industry:... (9/15/2025)

NHSA Issues the Regulations on DRG/DIP Healthc... (9/13/2025)

GRIT Biotech Raises CNY 380M in Series C... (10/3/2025) TJ Biopharma Secures CNY 600M to Advanc... (10/3/2025) Santen and RemeGen Files Chinese BLA for... (10/3/2025) OncoC4 Raises $50M in Series B to Advanc... (10/3/2025) BeOne and AbbVie Resolve P... (10/3/2025) Medilink Initiates U.S. Phase 1/2 Trial ... (10/3/2025) Baidu-Backed Biotech Start-up Aims to Ov... (10/3/2025) Full-Life Tech Nets $77M to Propel Radio... (10/1/2025) China Rolls Out 2025 Pharmacopoeia to Sh... (10/1/2025) CSPC Unit Accelerates Hong Kong Listing ... (10/1/2025) Binhui Biopharma Seeks Hong Kong Listing (10/1/2025) Chinese Drugmakers Face Mounting Risks F... (9/30/2025) China Issues Detailed Rules on Pre-Appro... (9/30/2025) Haixi Pharma Files for Hong Kong IPO (9/30/2025) China's Biopharma Sector Sees Surge in I... (9/30/2025) Wuhan Binhui Biopharma Files for Hong Ko... (9/30/2025) China Faces New Pressure as U.S. Eyes Mi... (9/29/2025) China Eliminates 30% Import Duty on Indi... (9/29/2025)

China's Innovative Drug Market Shows Diverging Trends B... Innovent's Weight-Loss Drug Challenges Western Giants i... China's PD-(L)1 Market Shows Continued Growth in H1 202... China to Become World's Third-Largest Innovative Drug M... China Drives Asia-Pacific Health Care Transformation Am...

Baidu-Backed Biotech Start-up Aims to Overtake AlphaFol... OncoC4 Raises $50M in Series B to Advance Next-Generati... TJ Biopharma Secures CNY 600M to Advance Late-Stage Ca... GRIT Biotech Raises CNY 380M in Series C Round Binhui Biopharma Seeks Hong Kong Listing

China Rolls Out 2025 Pharmacopoeia to Sharpen Drug Over... China Issues Detailed Rules on Pre-Approval Import of O... CDE Seeks Public Input on Clinical Evaluation Guideline... CDE Solicits Comments on Clinical Evaluation Guidelines... CDE Solicits Comments on Draft ICH Q3E Guideline for Ex...

China Expands Medical Insurance Coverage for Rare Disea... China Unveils New Rules for 11th Round of National Cent... China Launches Pilot Program for Real-World Comprehensi... China to Incorporate HPV Vaccines into National Immuniz... NHSA Seeks Feedback on Draft Implementation Rules for M...

BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ... SAMR Orders Simcere to Reverse Unnotified Merger Over C...

China Faces New Pressure as U.S. Eyes Middle East for D... FDA Issues Warning to Chengdu Biopharma Over cGMP Viola... China's Sharp API Price Cuts Jeopardize India's Self-Re... China Produces Dozens of Drugs Below Market Price – U.... India Moves to Set Minimum Import Prices to Protect Pha...

Medilink Initiates U.S. Phase 1/2 Trial for VEGF-Target... Santen and RemeGen Files Chinese BLA for RC28-E SystImmune to Unveil New Clinical Data on Two ADC Progr... Fosun Kairui Submits Marketing Application for Brexucab... NMPA Accepts Alphamab's NDA for HER2 BsAb in Gastric C...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...